New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
Jose Baselga JOSE BASELGA, Vall d’Hebron Hospital, Barcelona RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. … Continue reading New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed